Urological Research Foundation's home page
About the Urological Research Foundation
Prostate Cancer Questions & Answers
Quest Newsletter Articles
Past Quest Publications
Media articles and interviews with Dr. Catalona
Dr. Catalona's journal articles from various publications
Dr. Catalona's genetic research for prostate cancer
Donate to the URF for prostate cancer research
View the New Patient Packet sent by Dr. Catalona
Post-Op Advice for patients
Links to other helpful prostate cancer websites
Litigation Briefs
Contact the Urological Research Foundation


Please consider a donation to the URF

Dr. William Catalona
Dr. Catalona's Talk
Man to Man

Dr. William Catalona
QUEST articles by
Jules Reichel
QUEST Newsletter

The QUEST is a FREE newsletter published three times a year by the Urological Research Foundation written to inform readers of the latest advances in urologic research, especially prostate cancer treatment.

To be added to our mailing list, you can subscribe on-line or by request letter. Please click here to subscribe to QUEST for the necessary forms.

QUEST is a free newsletter but we appreciate your support in helping the Urological Research Foundation continue to make this publication informative and useful to its readers.

Additional QUEST Articles
Return to Quest Articles of High Interest
Article 1 of 82
PSA Screening Is Saving Thousands of Lives
By William J. Catalona, MD
Before PSA screening for early detection of prostate cancer, more than two thirds of men treated for the disease had incurable cancer that had spread beyond the prostate at the time of diagnosis and treatment....

/quest/Spring2010/article1.html
Back to top
Article 2 of 82
If Only We Knew Ahead of Time: The Role of Genetics in Diagnosis and Treatment of Prostate Cancer
By Cecilia Lacks, PhD based upon reported research: Brian T. Helfand, MD; Matthias Hofer, MD; Donghui Kan; & William J. Catalona, MD
Two major problems in the diagnosis and treatment of prostate cancer are not knowing: 1. who is at risk for the disease and 2. who is at risk for aggressive forms of the disease. Answers to both of these questions would do a great deal to make tes...

/quest/Spring2010/article2.html
Back to top
Article 3 of 82
PSA Cancer Screening, Much Like A Seat Belt, Is A Wise Choice For Men
By Patrick Walsh, MD (© and reprint permission of US News And World Report)
Prostate cancer, the most common cancer in U.S. men and the second-most common cause of cancer deaths, often produces no symptoms until it is too far advanced to cure. That’s why in 1990, before there was PSA testing, only 68 percent of newly diagnos...

/quest/Spring2010/article3.html
Back to top
Article 4 of 82
Ignorance is Bliss When it Comes to Prostate Cancer
By Rick Lyke
The American Cancer Society is telling men to pull up their pants, roll down their sleeves and not to worry about that prostate cancer thing. Citing difficulties in determining who should be treated when cancer is found, the American Cancer Societ...

/quest/Spring2010/article4.html
Back to top
Article 5 of 82
Diagnosed at 1.1 PSA Rising: The Speed Could Be Everything
By Cissy Lacks
At age 51, Dave Mayber considered himself lucky to be diagnosed with prostate cancer – and not a different cancer. “As scary as being diagnosed with cancer is, prostate cancer has a pretty good cure rate, and I had been plenty scared before,” Mayb...

/quest/Spring2010/article5.html
Back to top
Article 6 of 82
2010 Research Studies
Dr. Catalona wishes to keep his patients and research participants updated on the findings of his prostate cancer research group by providing brief lay summaries in QUEST. These summaries are from studies prepared by Dr. Catalona and his research ...

/quest/Spring2010/article6.html
Back to top
Article 7 of 82
“Watchful Waiting” Is Really “Wishful Waiting” for Many Patients
By William J. Catalona, MD
One option now offered to men who are diagnosed with seemingly less aggressive prostate cancer is active surveillance or “watchful waiting.”...

/quest/Winter2009/article1.html
Back to top
Article 8 of 82
Robotic Prostatectomy: The Emperor's New Clothes?
By William J. Catalona, MD
I believe treatment of prostate cancer by removal of the prostate with robot-assisted laparoscopic surgery could set back by years some of the gains that have been achieved in the successful treatment of prostate cancer....

/quest/Winter2009/article2.html
Back to top
Article 9 of 82
Dr. Catalona's Position On The Life-Saving Benefits of PSA Screening
The subject of prostate cancer screening continues to draw media attention. Dr. Catalona believes the coverage is confusing men who are making decisions about PSA screening and early detection for prostate cancer. His concern is that men, whose...

/quest/Winter2009/article3.html
Back to top
Article 10 of 82
Explaining PSA Testing
By Stacy Loeb, MD and William J. Catalona, MD (Medical Economics)
Unlike many other malignancies, symptoms are uncommon early in the course of prostate cancer....

/quest/Winter2009/article4.html
Back to top
Article 11 of 82
AUA Reaffirms Strong Support of PSA Testing (release from the American Urological Association 11.02.2009)
The American Urological Association (AUA) is aware of recent news reports disparaging prostate cancer testing. We are concerned that these reports are causing significant confusion for patients and we wish to clarify our recommendations on prostate c...

/quest/Winter2009/article5.html
Back to top
Article 12 of 82
Statins Might Have A Good Effect in Reducing Prostate Cancer Aggressiveness
Some studies have suggested that statins, in addition to their benefits for prevention of heart disease, might reduce the risk of the aggressive forms of prostate cancer....

/quest/Winter2009/article6.html
Back to top
Article 13 of 82
More Findings Link Finasteride to High-Grade Tumors
Finasteride and its link to masking high-grade prostate cancer has been the topic of several articles in previous Quests. (See the URF website: www.drcatalona.com)...

/quest/Winter2009/article7.html
Back to top
Article 14 of 82
One Guy To Another: Beer Geek to PSA Geek: A Life Saved – One Guy to Another
By Cissy Lacks
There's something to be said for a casual conversation between friends. It's how Rick Lyke committed to getting a PSA test, how it most likely saved him from advanced prostate cancer, and how he became an effective advocate for early detection of ...

/quest/Winter2009/article8.html
Back to top
Article 15 of 82
Detecting the Undetectable: New Technology Could Define New PSA “Zero”
Ateam of Northwestern University researchers, using an extremely sensitive tool based on nanotechnology, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy....

/quest/Winter2009/article9.html
Back to top
Article 16 of 82
deCODE Discovers Four New Risk Factors for Prostate Cancer
By deCODE Genetics and Dr. William J. Catalona
In September of this year, deCODE Genetics announced that a team of its scientists discovered four novel single-letter variations in the sequence of the human genome (SNPs) conferring increased risk of prostate cancer. (online edition of Nature Genet...

/quest/Winter2009/article10.html
Back to top
Article 17 of 82
Report On Genetic Research Of Dr. Catalona And His Research Group
Dr. Catalona and his research group continue their important research on the genetics of prostate cancer supported by the Urological Research Foundation. They made several presentations at a recent Annual AUA meeting related to their most recent find...

quest/quest_fall09_9.htm
Back to top
Article 18 of 82
An Oral Surgeon Becomes A Patient: Going for the Best Chance of Cure
By Cissy Lacks
Dr. Ben Smith is a "go to" and "get it over" kind of guy. That's why, looking back, he wishes his general practitioner had been more up to date on recommended practices when Smith's PSA first started going up and why he wishes he had educated hims...

quest/quest_fall09_8.htm
Back to top
Article 19 of 82
PSA Saves Lives: My Husband’s Advanced Prostate Cancer Didn't Have to Happen
By Martha E. Shenton, Ph.D
I read with interest, alarm, and, then horror, an article in the New York Times, July 17, 2009, entitled “In Push for Cancer Screening, Limited Benefits.” Interest, because I was hoping to read an intelligent and thoughtful article....

quest/quest_fall09_7.htm
Back to top
Article 20 of 82
Wanting The Best In Health Care: Making Sure of Universal Coverage For Early Detection Prostate Cancer Screening
Reform of the United States health care system is being debated in Congress and proposals are in discussion stages. We want our readers to be aware of how the current health care reform proposals could affect access to early detection and treatmen...

quest/quest_fall09_6.htm
Back to top
Article 21 of 82
Prostate cancer: Wait and watch - or not?
By Lisa Priest (Globe ad Mail, Canada)
(Dr. Catalona was a resource for this article. Courtesy of Globe and Mail, we are reprinting that portion of the article which relied on information and comments from him.) One of the problems with active surveillance, Dr. Catalona said, is that th...

/quest/quest_spring09_6.htm
Back to top
Article 22 of 82
A School Principal Shares His Lessons on Prostate Cancer
By Cissy Lacks
When Mark Dugan was diagnosed with prostate cancer, shortly after his 55th birthday, he had a lot of people to tell and he wasn’t sure how to tell them. First were his wife, two adult children, two adult stepchildren, two brothers and a sister. An...

/quest/quest_spring09_7.htm
Back to top
Article 23 of 82
Cancer Anyone? An Unwelcome Invitation: No RSVP Necessary
By Epa Rosa
It was a cold late afternoon in January of 2008 when I got the phone call from my doctor: "Epa. I have the report of your prostate biopsy. Why don't you come to my office? We need to talk"....

/quest/quest_winter08_4.htm
Back to top
Article 24 of 82
Bringing His Good Business Sense to the URF
By Cissy Lacks
Frank Bick has good business sense. His successes and experience have helped many a not-for-profit organization. And because of his family’s history with prostate cancer, the Urological Research Foundation has been one of the beneficiaries. Bick has ...

/quest/quest_winter08_5.htm
Back to top
Article 25 of 82
Prostate Cancer: An Equal Opportunity Disease
By Cissy Lacks
Prostate cancer is an equal opportunity disease. It can strike any man at any time. And it struck Anthony. F Sansone, Sr. at age 64 in 1990. ...

http://www.drcatalona.com/quest/quest_fall08_6.htm
Back to top
Article 26 of 82
One PSA to Another
By Cissy Lacks
Jess Smith was 62 years old and had never taken a PSA test even though PSA was part of his entire adult life. For the 38 years he had been in radio and broadcasting, PSA meant public service announcement. At the urging of a friend who had been diag...

/quest/quest_spring2008_3.htm
Back to top
Article 27 of 82
Still In His prime
By Cissy Lacks
Dr. Bruce Seidberg was diagnosed with prostate cancer at the age of 59, almost 10 years ago....

quest/quest_winter07_4.asp
Back to top
Article 28 of 82
Recovery: Twenty Years Later
By Cissy Lacks
Patrick Prader is celebrating a 20-year anniversary. In the summer of 1987, he was diagnosed– only four hours apart–with prostate cancer and sinus cancer. “You sure know how to mess up a fellow’s weekend,” Prader said to one of the doctors. ...

quest/quest_fall07_5.asp
Back to top
Article 29 of 82
Clinical Trials: Sometimes Good, Sometimes Not A Very Difficult Decision
By Jules Reichel
Quest readers know about the enormous progress in effective screening for prostate cancer. Advances have also been made with prostate cancer therapies including: early use of surgery, or radiation, or surgery followed by radiation (especially in t...

quest/quest_fall07_8.asp
Back to top
Article 30 of 82
One Man to Another Drug Therapies for Advanced Disease: A Positive View
By Jules Reichel
The role of drug therapies is mostly to provide a treatment option when surgery and radiation therapy are less likely to work. The experts on drug therapies are the medical oncologists like Dr. Sartor, who kindly agreed to discuss options and issues ...

quest/quest_spring07_6.asp
Back to top
Article 31 of 82
Training for Triathlon Temporarily Interrupted By Prostate Cancer Diagnosis
By Anthony Effinger
One day in Chicago, Dave Bigg is about to drink a few beers with his buddies and divvy up Cubs baseball tickets when his cell phone rings. It's the doctor, and he doesn't like what he sees. Bigg's biopsy looks bad. The cells from his prostate are...

quest/quest_spring07_3.asp
Back to top
Article 32 of 82
No More Prostate Excuses
By Richard N. Atkins
If lost in the wilderness, search and rescue experts will tell you the first rule is to stay put and do nothing. Help will find you. Not true for prostate cancer. And with good reason, prostate cancer is far more fatal than most of the combined a...

quest/quest_Winter06_2.asp
Back to top
Article 33 of 82
Celebrate Life! And Then There Were Three
By Cecilia Lacks
Bob Buhle, single and not dating anyone, was diagnosed with prostate cancer in 2003 at age 39. One week after his surgery, Buhle met his wife to be, Heidi. And on October 14, 2006, Heidi gave birth to their first child. His story, full of hope ...

quest/quest_Winter06_5.asp
Back to top
Article 34 of 82
ONE MAN TO ANOTHER Watchful Waiting: Seldom a Good Treatment Option
By Jules Reichel
I’m the Secretary of the URF Board and a patient of Dr. Catalona. He performed my radical prostatectomy in September 1997. I’ve written in QUEST for 5 years. I study and write and counsel and lecture, but I am not a doctor. ...

quest/quest_Winter06_7.asp
Back to top
Article 35 of 82
Life After Prostate Cancer: Fishing, Canoeing and Camping
By Cecilia Lacks
Before Marty Koch was diagnosed with prostate cancer, at the age of 49, he had never needed stitches for anything – much less been in a hospital. Needless to say, he was scared. Koch described himself as “being on the edge.” He had fears of “dyi...

quest/quest_fall06_4.asp
Back to top
Article 36 of 82
ONE MAN TO ANOTHER The Controversial Topic of Nutrition and Supplements “Every unsolved disease cries out for garlic around the neck.”
By Jules Reichel
Does good nutrition prevent or cure prostate cancer? When I was a little boy, a kid on the next block had a distorted body from polio. I recall being afraid to talk to him. I asked my mom whether I could wear garlic around my neck like the other b...

quest/quest_fall06_8.asp
Back to top
Article 37 of 82
She Fights Off Coyote to Rescue Her Pooch
By by Josh Noel, Chicago Tribune Staff Reporter (excerpt reprinted courtesy of the Chicago Tribune)
Cecilia (Cissy) Lacks, Managing Editor of Quest, was on the front page of the Chicago Tribune when the paper covered the story of her miniature poodle being attacked by a coyote in the afternoon, on a mall parking lot in a Chicago suburb. Cecilia, Dr...

quest/quest_fall06_9.asp
Back to top
Article 38 of 82
URF and Dr. Catalona’s Prostate Cancer Research Collaborations Help Other Scientists
The possibility that some prostate cancers might be caused by a virus has received media attention in the last few months....

quest/quest_spring06_4.asp
Back to top
Article 39 of 82
ONE MAN TO ANOTHER: Surgery Plus Radiation When Required: Is It the Best Choice?
By Jules Reichel
My prior article in QUEST, Winter 2005, described a “universal” approach to achieving a high likelihood of long-term remission and a return to a positive life for a wide range of prostate cancer patients who have low-risk to high-risk disease....

quest/quest_spring06_9.asp
Back to top
Article 40 of 82
Pioneer of PSA Screen Sounds Off
By Shirley Ruedy (reprinted courtesy of The Gazette, Cedar Rapids, Iowa)
He’s the guy who pioneered the PSA test as a screening tool for prostate cancer. He thinks doctors are dead wrong who think men with low PSA levels only need the test every other year. He also says men should start it at age 40, not 50, as most ex...

quest/Winter05/quest_winter05_2.asp
Back to top
Article 41 of 82
SPORE: Research Projects and Patient Advocates
QUEST would like its readers to know about SPORE (Specialized Program of Research Excellence) from the National Institutes of Health and the role patients can have in supporting prostate cancer research. Dr. Catalona has begun a collection o...

quest/Winter05/quest_winter05_4.asp
Back to top
Article 42 of 82
One Man to Another Surgery plus radiation when required offers an almost universal approach for the PSA era (The precedent-setting study of Dr. Michael Bolla)
By Jules Reichel
A Universal Approach The goals for treating prostate cancer are to achieve long-term remission, and to return patients to a positive life, largely as before, regardless of the medical situation at diagnosis. This ability to respond effectively...

quest/Winter05/quest_winter05_6.asp
Back to top
Article 43 of 82
18 Holes of Golf and a Radical Prostatectomy or (Obi-Wan, Me, and a Radical Prostatectomy)
By Stephen G. Avgerinos
One year after my radical prostatectomy, I was driving home after 18 holes of golf and a wonderful dinner. Dr. Catalona, who I now refer to secretly as Obi-Wan, had removed my prostate with nerve sparing surgery. What was running through my min...

quest/Winter05/quest_winter05_7.asp
Back to top
Article 44 of 82
Grant Supports Prostate Cancer Research
Many companies establish foundations to support the research and educational activities of not for profit organizations. Often, these foundations consider supporting organizations recommended by their employees. James Schneiders , vice-president o...

quest/Winter05/quest_winter05_10.asp
Back to top
Article 45 of 82
One Man to Another The Pathology Point of View (Patient, Know Thy Tumor)
By Jules Reichel
The Pathology Challenge Prostate cancer begins as cellular mutations, or “cancers”, in the prostate, produced by our DNA/RNA (genetic) system for establishing cells. The cause for the cancerous cells can be the environment, heredity, or normal...

quest/Fall05/quest_fall05_5.asp
Back to top
Article 46 of 82
TP and Me: Prostate Cancer and Hope
By Michael Murray
Late last August, at the time of the New Moon, on an Island in Northern Lake Michigan, a hopeful and loving couple was able-under trying circumstances- to give life to a child nicknamed “TP” who rests in my arms as I write these words. These words,...

quest/quest_fall05_3.htm
Back to top
Article 47 of 82
Lesson from a Patient: Making the Recovery Work Better
By Michael Murray, PhD, JD
When I first learned I had prostate cancer, I heard from people about the “numbers game,” the odds related to prostate cancer: how many men get it; how long they live after diagnosis; how many stay continent; how many stay potent. The conversation...

quest/Spring05/quest_spring05_5.asp
Back to top
Article 48 of 82
One Man to Another New-Era Of Treatment vs. PSA-Era
By Jules Reichel
In general, the New Era strategy for prostate cancer is to screen and possibly treat men earlier when the cancer is limited and weak. The goal is to keep a patient’s life as it was before the diagnosis and ensuing treatment. The dramatic redu...

quest/Spring05/quest_spring05_6.asp
Back to top
Article 49 of 82
Faces Behind Blood and Tissue Samples
Prostate cancer research samples are much more than tissue stored in a freezer at a research center. Behind each sample is a person, a life story and a family history. The McCammons Carol: My husband, Dr. Robert McCammon died this January....

quest/Spring05/quest_spring05_7.asp
Back to top
Article 50 of 82
Prostate Cancer Survivor Who Is “Better Than Cured”
By Cecilia Lacks
At 44 years old, Danny More was a successful agent for coaches and mangers in professional and college football. At 44 years old, Danny More was also a prostate cancer patient. Now, at 49, More is still a successful agent and, according to hi...

quest/Winter04/quest_winter04_2.asp
Back to top
Article 51 of 82
One Man to Another
A New Treatment Era: Better Outcomes for Prostate Cancer
By Jules Reichel
A revolution is going on in the detection and treatment of prostate cancer, and I want to make sure that everyone knows about it. 1990’s: First Era Of Treatment Success After about 80 years of poor outcomes from both surgical and radiation...

quest/Winter04/quest_winter04_7.asp
Back to top
Article 52 of 82
Running the Boston Marathon:
Jim Carrick’s 1-year Anniversary with a RRP
By Cecilia Lacks
One year to the day after Jim Carrick’s operation to remove his cancerous prostate, he ran the Boston Marathon. Racing isn’t important to him. But his wife, three daughters, friends, business, and local community are. The Marathon was to show h...

quest/Summer04/quest_summer04_3.asp
Back to top
Article 53 of 82
One Man to Another
New Practices + Improved Techniques = Better Outcomes
By Jules Reichel
NCCN Guidelines For Early Detection My favorite “Practice Guidelines” for the treatment of prostate cancer (CaP) are prepared by the National Comprehensive Cancer Network (NCCN) group of medical centers, which are the 19 comprehensive centers of e...

quest/Summer04/quest_summer04_5.asp
Back to top
Article 54 of 82
Familial Prostate Cancer Screening Program Opens at Northwestern Memorial Hospital
By William J. Catalona, MD
We are enrolling people with a family history of prostate cancer in research studies that aim to map the genetics of prostate cancer We have opened a Familial Prostate Cancer Screening Program at Northwestern Memorial Hospital in Chicago to he...

quest/Summer04/quest_summer04_6.asp
Back to top
Article 55 of 82
John Clark’s Adventures:
Kayaking, Bicycling, and Prostate Cancer
By Cecilia Lacks
John Clark is an athlete – a middle-aged athlete who was treated for prostate cancer last year. His career, until he retired at 54, was athletic director for St. Lawrence University. His children, seven of them, are athletes too. Naturally ...

quest/Spring04/quest_spring04_2.asp
Back to top
Article 56 of 82
One Man to Another
Where We Stand In Trying To Be “Cured”
By Jules Reichel
Why a patient's column? This is not a doctor’s column. I am a patient of Dr. Catalona and a member of the URF Board. This column attempts to provide a patient’s perspective on prostate cancer to the readers of QUEST. To review my prior columns, p...

quest/Spring04/quest_spring04_5.asp
Back to top
Article 57 of 82
One Man to Another
Revolution in Screening for Prostate Cancer
By Jules Reichel
Dr. Catalona recommends lower PSA screening threshold The July 24 issue of the New England Journal of Medicine contains a study by Dr. Catalona and his associates that completes his 8-year series of research publications on lowering the PSA screen...

quest/quest_winter03_5.asp
Back to top
Article 58 of 82
One Man to Another
Goldilocks and Prostate Cancer
By Jules Reichel
We, too, are looking for "just right" treatment of prostate cancer. Our doctors are getting closer to finding such an approach. Although no study has as yet described a complete answer, some early results may be helpful to patients. Being treated ...

quest/quest_fall03_6.asp
Back to top
Article 59 of 82
One Man to Another
It's In the Numbers
By Jules Reichel
My journey with prostate cancer began by learning about the individual numbers that are used for specifying the disease. In my case they were: Stage T1c (elevated PSA with no palpable tumor), PSA=5.4ng/ml (nanograms of protein per milliliter of blood...

quest/quest_spring03_6.htm
Back to top
Article 60 of 82
Update: Prostate Cancer Research
Looking for Prostate Cancer Genes
At a recent CaP CURE conference, Dr. Catalona presented summaries of recent genetic studies conducted by his collaborative prostate cancer research group. "We are trying to find possible genomic regions associated with prostate cancer," Dr. Catalo...

quest/quest_winter2002_1.htm
Back to top
Article 61 of 82
One Man to Another
Statistics and Prognosis
By Jules Reichel
Based upon his case history, Jules Reichel discusses the statistics of prostate cancer and how they relate to a patient's prognosis. A second topic covered is considerations in choosing a doctor for treatment of prostate cancer. Why a patient's co...

quest/quest_winter2002_6.htm
Back to top
Article 62 of 82
Reports from Dr. Catalona's Follow-up Studies
Comparing Treatments Radical prostatectomy provides a higher 7-year PSA progression-free rate than other treatments for localized prostate cancer. A member of Dr. Catalona's research team in St. Louis, Julie Krygiel, reported preliminary result...

quest/quest_winter2002_7.htm
Back to top
Article 63 of 82
One Man to Another
Medical Specifications of Prostate Cancer
By Jules Reichel
This article discusses medical specifications of prostate cancer: clinical stage, PSA reading, DRE findings, number and percentage of cancer in biopsy cores, and Gleason score. It answers the questions: What do I do with these terms of the specifica...

quest\quest_fall2002_3.htm
Back to top
Article 64 of 82
Findings From Dr. Catalona's Collaborative Research Group
Annual PSA and DRE Are Recommended Currently, annual PSA tests and (DRE) digital rectal exams are recommended by both the American Cancer Society and the American Urological Association. Recently, some authors have suggested that annual tests ...

quest\quest_fall2002_2.htm
Back to top
Article 65 of 82
Key to High Cure Rate Is Early Diagnosis
By William J. Catalona, M.D.
The key to good results in treating localized prostate cancer is to make the diagnosis as early as possible. Now, at least 80% of prostate cancers can be detected while they are still contained within the prostate, and 90% of prostate cancers can ...

quest/quest_spring2002_2.htm
Back to top
Article 66 of 82
Does PSA Screening Find Cancers That Could Be Better Left Alone?
By William J. Catalona, M.D.
Some material in recent articles suggest that PSA screening finds prostate cancers that are then treated when they don't need to be or when the treatment carries more risk than the presence of the cancer. In other words, PSA screening is finding c...

quest/quest_spring2002_4.htm
Back to top
Article 67 of 82
One Man to Another
Emotions, Issues and Facts
By Jules Reichel
This column is the first of a series in which patient and patient advocate Jules Reichel discusses emotions, issues, and facts surrounding the treatment of prostate cancer. Why a patient's column? This is not a doctor's column. I am, in fact, a...

quest/quest_spring2002_5.htm
Back to top
Article 68 of 82
URF Participating in New Method of Drug Discovery
By Cecilia Lacks, Ph.D.
At a recent board meeting of the Urological Research Foundation, Dr. Catalona told members that he is actively participating in new work which can greatly affect the detection and treatment of prostate cancer. Up until now, many standard treatment...

quest/quest_winter2001_1.htm
Back to top
Article 69 of 82
The Hepsin Discovery:
Potential for Hope in the Treatment of Prostate Cancer
By Cecilia Lacks, Ph.D.
Prostate cancer specimens provided by Dr. William Catalona and financial support from the Urological Research Foundation have helped in the discovery of a protein, hepsin, that hopefully will lead to dramatic new methods for the treatment of prostate...

quest/quest_winter2001_2.htm
Back to top
Article 70 of 82
Solving the Prostate Cancer Puzzle
By William J. Catalona, M.D.
If you have a jigsaw puzzle and it's totally disassembled and someone hands you a piece and it's blue, the most difficult task is to figure out where that first piece goes. Then, every piece you put in gets easier than the one before it. When a...

quest/quest_winter2001_3.htm
Back to top
Article 71 of 82
Microarray: the Word to Know
New Technology For New Research in Prostate Cancer Treatments
By Cecilia Lacks, Ph.D.
Just five years ago, genes were studied one by one. Now, thousands are studied at one time with the development of a new technology – the DNA microarray. A particular cell contains the entire complement of 30,000 genes and these genes send message...

quest/quest_winter2001_4.htm
Back to top
Article 72 of 82
Gene Expression Studies:
Using Prostate Cancer Specimens from Dr. Catalona
By Cecilia Lacks, Ph.D.
Two noted scientists working in Boston are using prostate cancer specimens from Dr. Catalona to further their research. Todd Golub, M.D. is a specialist in the genetics of cancer at the MIT Center for Genome Research and at the Dana Farber Cancer ...

quest/quest_winter2001_6.htm
Back to top
Article 73 of 82
Latest Developments in Prostate Cancer Treatment
By William J. Catalona, M.D.
Taking the Information Plunge... Each year, Dr. Catalona presents a course at the American Urological Association Meeting in which he reviews selected articles from the medical literature to update urologists on the latest developments in prostate c...

quest/quest_fall2001_1.htm
Back to top
Article 74 of 82
Progress in Prostate Cancer Treatment and Research
By William J. Catalona, M.D.
Dr. Catalona was the keynote speaker for the Florida Cancer Education Network's Gala 2001. Other participants included Senator Connie Mack and Senator Bob Dole (via videotape). Dr. Catalona's speech on the progress made in prostate cancer treatment a...

quest/quest_fall2001_2.htm
Back to top
Article 75 of 82
Free PSA Less Helpful for PSA 2.6 to 4
By William J. Catalona, M.D.
Various components of the PSA Study were featured in presentations for a recent American Urological Association meeting by William J. Catalona, MD; Kimberly Roehl, MPH; and JoAnn Antenor, BS. We thought the QUEST readers would be interested in their ...

quest/quest_fall2001_4.htm
Back to top
Article 76 of 82
Opportunity to Help:
For Prostate-Cancer Free African-Americans
By William J. Catalona, M.D.
Being healthy is a gift that can be shared with future generations of African-American males. Dr. Catalona is inviting prostate-cancer free African-American men to participate in a control group for an important genetic study on prostate cancer an...

quest/quest_fall2001_5.htm
Back to top
Article 77 of 82
Screening High-Risk Men in Their Forties
By William J. Catalona, M.D.
African-American men and men with a family history of prostate cancer (particularly those with an affected brother or father) are at higher risk to develop prostate cancer. In high-risk patients, prostate cancer tends to occur at a younger age. Th...

quest/quest_fall2001_6.htm
Back to top
Article 78 of 82
Prostate Cancer Research Is Group Effort
By William J. Catalona, M.D.
Projects in scientific research are not done by one person anymore. Often, they are a team effort involving scientists from all parts of the United States and other countries as well. The collaborative research groups on prostate cancer coordin...

quest/quest_fall2001_7.htm
Back to top
Article 79 of 82
In Search of Prostate Cancer Genes:
A Journey of DNA Samples
By Cecilia Lacks, Ph.D.
The journey of a constitutional DNA sample, the DNA that makes up an individual's human genome, most often begins with taking someone's blood. Blood is an excellent source of lots of fresh cells so blood samples are a most ...

quest/quest_article_v10n4.htm
Back to top
Article 80 of 82
A Surgeon's View: Why Genetics? Why Now?
By Cecilia Lacks, Ph.D.
In a brief look back at his career, surgeon William Catalona answers the question of why genetics is the next tool for researching the causes of and treatments for prostate cancer. When Dr. Catalona began his medical career, his goal was to improve...

/quest/quest_article_v10n1.htm
Back to top
Article 81 of 82
Different From Other Diseases:
Genetic Research on Prostate Cancer
By Cecilia Lacks, Ph.D.
While the methods and goals of genetic research are similar, the diseases are not. Prostate cancer has its own set of circumstances with which genetic researchers have to contend. Most Common Cancer in Men First and foremost is the fact that p...

quest/quest_article_v10n2.htm
Back to top
Article 82 of 82
Genetic Research Report New Regions in DNA Statistically Associated with Prostate Cancer
By William J. Catalona, M.D.
Dr. Catalona and his research collaborators have just completed a linkage analysis of DNA obtained from blood samples collected over ten years from brothers with prostate cancer.A linkage analysis is a statistical method to determine if two kinds of ...

/quest/quest_article_v8n4.htm
Back to top
Return to Quest Articles of High Interest


Home    |    About the URF   |    Q & A - Prostate Cancer   |    Quest Articles
Journal Articles   |    National Media   |    Suggested Reading   |    Genetic Research
Donations   |    New Patient Packet   |    Post-Op Advice   |    Helpful Links   |    Contact Us